KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Revenue (2016 - 2025)

Bausch Health Companies' Revenue history spans 17 years, with the latest figure at $2.8 billion for Q4 2025.

  • For Q4 2025, Revenue rose 9.26% year-over-year to $2.8 billion; the TTM value through Dec 2025 reached $10.3 billion, up 6.66%, while the annual FY2025 figure was $10.3 billion, 6.66% up from the prior year.
  • Revenue for Q4 2025 was $2.8 billion at Bausch Health Companies, up from $2.7 billion in the prior quarter.
  • Across five years, Revenue topped out at $7.2 billion in Q4 2021 and bottomed at $1.9 billion in Q1 2022.
  • The 5-year median for Revenue is $2.2 billion (2022), against an average of $2.5 billion.
  • The largest annual shift saw Revenue skyrocketed 227.16% in 2021 before it crashed 69.71% in 2022.
  • A 5-year view of Revenue shows it stood at $7.2 billion in 2021, then plummeted by 69.71% to $2.2 billion in 2022, then rose by 9.8% to $2.4 billion in 2023, then rose by 6.27% to $2.6 billion in 2024, then increased by 9.26% to $2.8 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Revenue are $2.8 billion (Q4 2025), $2.7 billion (Q3 2025), and $2.5 billion (Q2 2025).